Similar articles

• Effects of interleukin-7 on proliferation of hematopoietic malignant cells.

  Masuda M, Motoji T, Oshimi K, Mizoguchi H. Masuda M, et al. Exp Hematol. 1990 Sep;18(8):965-7. Exp Hematol. 1990. PMID: 2387346 No abstract available.
• Interleukin 7 receptor mediates the activation of phosphatidylinositol-3 kinase in human B-cell precursors.

  Dadi HK, Ke S, Roifman CM. Dadi HK, et al. Biochem Biophys Res Commun. 1993 Apr 30;192(2):459-64. doi: 10.1006/bbrc.1993.1437. Biochem Biophys Res Commun. 1993. PMID: 8387278
• [Establishment and characterization of an interleukin-2 receptor bearing a Burkitt's lymphoma cell line (ABL-2)].

  Matsuo Y, Motoori T, Irie K, Natori H, Hayashi A, Mizote H, Sagawa K, Yokoyama MM. Matsuo Y, et al. Nihon Ketsueki Gakkai Zasshi. 1985 Aug;48(5):1187-97. Nihon Ketsueki Gakkai Zasshi. 1985. PMID: 3934897 Japanese. No abstract available.
• Interleukin-7 and malignant T cells.

  Merle-Béral H, Schmitt C, Mossalayi D, Bismuth G, Dalloul A, Mentz F. Merle-Béral H, et al. Nouv Rev Fr Hematol (1978). 1993 Jun;35(3):231-2. Nouv Rev Fr Hematol (1978). 1993. PMID: 8337134 Review. No abstract available.
• Characterization of hematopoietic growth factor receptors.

  Park LS, Gillis S. Park LS, et al. Prog Clin Biol Res. 1990;352:189-96. Prog Clin Biol Res. 1990. PMID: 1698297 Review. No abstract available.